Symbols / WAT Stock $307.12 -0.68% Waters Corporation

Healthcare • Diagnostics & Research • United States • NYQ
WAT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Dr. Udit Batra Ph.D.
Exch · Country NYQ · United States
Market Cap 30.15B
Enterprise Value 31.09B
Income 642.63M
Sales 3.17B
FCF (ttm) 427.16M
Book/sh 43.01
Cash/sh 5.99
Employees 7,900
Insider 10d
IPO Nov 17, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 28.57
Forward P/E 18.79
PEG 1.34
P/S 9.52
P/B 7.14
P/C
EV/EBITDA 28.41
EV/Sales 9.82
Quick Ratio 1.14
Current Ratio 1.73
Debt/Eq 60.28
LT Debt/Eq
EPS (ttm) 10.75
EPS next Y 16.34
EPS Growth -3.10%
Revenue Growth 6.80%
EPS Gr Q/Q -2.70%
Rev Gr Q/Q
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-09
ROA 11.52%
ROE 29.28%
ROIC
Gross Margin 59.28%
Oper. Margin 33.76%
Profit Margin 20.30%
Shs Outstand 98.17M
Shs Float 97.96M
Insider Own 0.11%
Instit Own 63.51%
Short Float 3.80%
Short Ratio 3.89
Short Interest 3.73M
52W High 414.15
vs 52W High -25.84%
52W Low 275.05
vs 52W Low 11.66%
Beta 1.20
Impl. Vol. 57.61%
Rel Volume 0.50
Avg Volume 1.23M
Volume 619.57K
Target (mean) $385.50
Tgt Median $377.50
Tgt Low $330.00
Tgt High $470.00
# Analysts 22
Recom Buy
Prev Close $309.23
Price $307.12
Change -0.68%
About

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$307.12
Low
$330.00
High
$470.00
Mean
$385.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-13 main UBS Neutral → Neutral $330
2026-03-25 main Deutsche Bank Hold → Hold $330
2026-02-23 main Morgan Stanley Equal-Weight → Equal-Weight $350
2026-02-11 main Wells Fargo Equal-Weight → Equal-Weight $355
2026-02-10 main UBS Neutral → Neutral $370
2026-02-10 reit Guggenheim Buy → Buy $440
2026-02-10 main B of A Securities Neutral → Neutral $350
2026-01-27 init HSBC — → Buy $460
2026-01-05 init William Blair — → Outperform
2025-12-15 main Wells Fargo Equal-Weight → Equal-Weight $415
2025-12-10 up Wolfe Research Peer Perform → Outperform $480
2025-12-02 init Morgan Stanley — → Equal-Weight $423
2025-11-05 main TD Cowen Hold → Hold $390
2025-11-05 main Wells Fargo Equal-Weight → Equal-Weight $385
2025-10-09 main JP Morgan Neutral → Neutral $325
2025-10-08 init Rothschild & Co — → Buy $390
2025-08-05 main Deutsche Bank Hold → Hold $315
2025-08-05 main Wells Fargo Equal-Weight → Equal-Weight $315
2025-08-04 main Jefferies Buy → Buy $385
2025-07-16 main Baird Outperform → Outperform $352
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-31 JIANG WEI Director 64 $0.00 $0
2026-03-31 KNIGHT HEATHER Director 68 $0.00 $0
2026-03-16 JIANG WEI Director 500 $289.46 $144,730
2026-03-06 FEARON RICHARD H Director 1,000 $306.34 $306,340
2026-02-25 CHAUBAL AMOL Chief Financial Officer 1,455 $0.00 $0
2026-02-25 BATRA UDIT Chief Executive Officer 5,165 $0.00 $0
2026-02-25 HUANG PEARL S. Director 23 $0.00 $0
2026-02-25 BENNETT JIANQING Officer 986 $0.00 $0
2026-02-25 JIANG WEI Director 23 $0.00 $0
2026-02-25 KNIGHT HEATHER Director 23 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3,165.29
+6.99%
2,958.39
+0.07%
2,956.42
-0.52%
2,971.96
Operating Revenue
3,165.29
+6.99%
2,958.39
+0.07%
2,956.42
-0.52%
2,971.96
Cost Of Revenue
1,288.82
+7.38%
1,200.20
+0.42%
1,195.22
-4.24%
1,248.18
Reconciled Cost Of Revenue
1,130.38
+7.10%
1,055.47
-0.60%
1,061.88
-5.54%
1,124.12
Gross Profit
1,876.46
+6.73%
1,758.19
-0.17%
1,761.19
+2.17%
1,723.77
Operating Expense
1,073.88
+16.69%
920.26
-2.46%
943.52
+12.25%
840.58
Research And Development
195.71
+6.93%
183.03
+4.62%
174.94
-0.71%
176.19
Selling General And Administration
830.37
+20.32%
690.15
-6.23%
736.01
+11.85%
658.03
Total Expenses
2,362.70
+11.42%
2,120.47
-0.85%
2,138.74
+2.39%
2,088.76
Operating Income
802.59
-4.22%
837.92
+2.48%
817.68
-7.42%
883.19
Total Operating Income As Reported
802.59
-2.88%
826.35
+1.06%
817.68
-6.38%
873.39
EBITDA
1,030.66
-0.55%
1,036.37
+3.53%
1,001.01
-1.58%
1,017.07
Normalized EBITDA
1,030.66
-1.65%
1,047.94
+4.69%
1,001.01
-2.52%
1,026.86
Reconciled Depreciation
206.24
+7.51%
191.82
+15.62%
165.91
+27.21%
130.42
EBIT
824.43
-2.38%
844.54
+1.13%
835.10
-5.81%
886.64
Total Unusual Items
0.00
+100.00%
-11.57
0.00
+100.00%
-9.80
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-11.57
0.00
+100.00%
-9.80
Special Income Charges
0.00
+100.00%
-11.57
0.00
+100.00%
-9.80
Other Special Charges
11.57
9.80
Impairment Of Capital Assets
0.00
Net Income
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Pretax Income
754.88
+0.00%
754.87
+2.53%
736.24
-12.13%
837.85
Net Non Operating Interest Income Expense
-50.77
+29.74%
-72.26
+12.13%
-82.24
-117.70%
-37.78
Interest Expense Non Operating
69.55
-22.45%
89.68
-9.29%
98.86
+102.60%
48.80
Net Interest Income
-50.77
+29.74%
-72.26
+12.13%
-82.24
-117.70%
-37.78
Interest Expense
69.55
-22.45%
89.68
-9.29%
98.86
+102.60%
48.80
Interest Income Non Operating
18.78
+7.81%
17.42
+4.78%
16.62
+50.83%
11.02
Interest Income
18.78
+7.81%
17.42
+4.78%
16.62
+50.83%
11.02
Other Income Expense
3.06
+128.36%
-10.79
-1437.30%
0.81
+110.66%
-7.57
Other Non Operating Income Expenses
3.06
+294.46%
0.78
-3.84%
0.81
-63.78%
2.23
Tax Provision
112.25
-4.09%
117.03
+24.49%
94.01
-27.74%
130.09
Tax Rate For Calcs
0.00
-3.87%
0.00
+21.39%
0.00
-17.62%
0.00
Tax Effect Of Unusual Items
0.00
+100.00%
-1.79
0.00
+100.00%
-1.52
Net Income Including Noncontrolling Interests
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Net Income From Continuing Operation Net Minority Interest
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Net Income From Continuing And Discontinued Operation
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Net Income Continuous Operations
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Normalized Income
642.63
-0.77%
647.61
+0.84%
642.23
-10.31%
716.03
Net Income Common Stockholders
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Diluted EPS
10.76
+0.47%
10.71
-1.20%
10.84
-7.59%
11.73
Basic EPS
10.80
+0.47%
10.75
-1.10%
10.87
-7.88%
11.80
Basic Average Shares
59.51
+0.30%
59.33
+0.44%
59.08
-1.52%
59.98
Diluted Average Shares
59.71
+0.26%
59.55
+0.48%
59.27
-1.76%
60.33
Diluted NI Availto Com Stockholders
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Amortization
47.79
+1.49%
47.09
+44.63%
32.56
+411.44%
6.37
Amortization Of Intangibles Income Statement
47.79
+1.49%
47.09
+44.63%
32.56
+411.44%
6.37
Depreciation Amortization Depletion Income Statement
47.79
+1.49%
47.09
+44.63%
32.56
+411.44%
6.37
Depreciation And Amortization In Income Statement
47.79
+1.49%
47.09
+44.63%
32.56
+411.44%
6.37
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5,076.55
+11.48%
4,553.80
-1.58%
4,626.85
+41.00%
3,281.45
Current Assets
2,147.64
+28.67%
1,669.11
-4.78%
1,752.87
-0.63%
1,763.90
Cash Cash Equivalents And Short Term Investments
587.83
+80.67%
325.36
-17.83%
395.97
-17.74%
481.39
Cash And Cash Equivalents
587.83
+80.67%
325.36
-17.65%
395.08
-17.78%
480.53
Other Short Term Investments
0.93
+4.01%
0.90
+4.18%
0.86
Receivables
828.84
+13.02%
733.37
+4.44%
702.17
-2.87%
722.89
Accounts Receivable
828.84
+13.02%
733.37
+4.44%
702.17
-2.87%
722.89
Gross Accounts Receivable
840.92
+12.48%
747.63
+3.62%
721.50
-2.13%
737.20
Allowance For Doubtful Accounts Receivable
-12.07
+15.38%
-14.27
+26.20%
-19.34
-35.11%
-14.31
Inventory
572.37
+19.93%
477.26
-7.55%
516.24
+13.28%
455.71
Raw Materials
234.63
+3.35%
227.03
-2.96%
233.95
+13.70%
205.76
Work In Process
28.16
+29.15%
21.80
+7.94%
20.20
+1.50%
19.90
Finished Goods
309.58
+35.53%
228.43
-12.84%
262.09
+13.93%
230.05
Other Current Assets
158.60
+19.13%
133.13
-3.87%
138.49
+33.28%
103.91
Total Non Current Assets
2,928.90
+1.53%
2,884.68
+0.37%
2,873.99
+89.38%
1,517.55
Net PPE
722.81
-0.36%
725.39
+0.24%
723.66
+8.22%
668.72
Gross PPE
1,563.07
+7.44%
1,454.86
-1.42%
1,475.80
+7.66%
1,370.85
Accumulated Depreciation
-840.26
-15.19%
-729.46
+3.01%
-752.13
-7.12%
-702.12
Properties
0.00
0.00
0.00
0.00
Land And Improvements
43.77
+6.89%
40.95
+14.90%
35.63
+2.80%
34.66
Buildings And Improvements
566.10
+3.37%
547.67
+12.07%
488.67
+9.81%
444.99
Machinery Furniture Equipment
36.02
+20.01%
30.01
+4.67%
28.68
-6.24%
30.58
Construction In Progress
48.21
+23.04%
39.18
-66.93%
118.49
-27.85%
164.22
Other Properties
824.49
+9.43%
753.43
+0.55%
749.32
+16.82%
641.45
Leases
44.49
+1.98%
43.62
-20.70%
55.01
+0.14%
54.93
Goodwill And Other Intangible Assets
1,898.26
+1.86%
1,863.63
-3.67%
1,934.63
+194.14%
657.73
Goodwill
1,340.08
+3.42%
1,295.72
-0.75%
1,305.45
+203.36%
430.33
Other Intangible Assets
558.18
-1.71%
567.91
-9.74%
629.19
+176.69%
227.40
Other Non Current Assets
307.83
+4.12%
295.67
+37.08%
215.69
+12.87%
191.10
Total Liabilities Net Minority Interest
2,515.31
-7.70%
2,725.29
-21.61%
3,476.51
+25.19%
2,776.97
Current Liabilities
1,239.50
+56.95%
789.76
+0.02%
789.58
+0.49%
785.74
Payables And Accrued Expenses
151.57
-43.90%
270.19
+24.51%
217.01
-8.74%
237.80
Payables
139.31
-46.13%
258.59
+26.16%
204.96
-9.25%
225.85
Accounts Payable
103.78
+3.85%
99.93
+17.98%
84.70
-9.21%
93.30
Current Accrued Expenses
12.26
+5.68%
11.60
-3.72%
12.05
+0.85%
11.95
Employee Benefits
43.92
-1.55%
44.61
-6.20%
47.56
+24.49%
38.20
Pensionand Other Post Retirement Benefit Plans Current
99.65
+6.05%
93.97
+35.42%
69.39
-32.83%
103.30
Total Tax Payable
35.53
-77.61%
158.66
+31.93%
120.26
-9.27%
132.54
Income Tax Payable
35.53
-77.61%
158.66
+31.93%
120.26
-9.27%
132.54
Current Debt And Capital Lease Obligation
491.09
+1823.06%
25.54
-67.19%
77.83
+1.83%
76.43
Current Debt
460.00
50.00
+0.00%
50.00
Other Current Borrowings
460.00
50.00
Current Capital Lease Obligation
31.09
+21.75%
25.54
-8.22%
27.82
+5.28%
26.43
Current Deferred Liabilities
266.54
+6.27%
250.81
-2.29%
256.68
+12.62%
227.91
Current Deferred Revenue
266.54
+6.27%
250.81
-2.29%
256.68
+12.62%
227.91
Other Current Liabilities
230.65
+54.53%
149.25
-11.51%
168.68
+20.22%
140.30
Total Non Current Liabilities Net Minority Interest
1,275.81
-34.08%
1,935.53
-27.97%
2,686.93
+34.94%
1,991.23
Long Term Debt And Capital Lease Obligation
999.99
-40.36%
1,676.81
-29.08%
2,364.44
+48.99%
1,586.99
Long Term Debt
947.45
-41.75%
1,626.49
-29.45%
2,305.51
+51.19%
1,524.88
Long Term Capital Lease Obligation
52.55
+4.43%
50.32
-14.61%
58.93
-5.12%
62.11
Non Current Pension And Other Postretirement Benefit Plans
43.92
-1.55%
44.61
-6.20%
47.56
+24.49%
38.20
Tradeand Other Payables Non Current
34.08
+12.39%
30.32
-77.89%
137.12
-44.82%
248.50
Other Non Current Liabilities
197.82
+7.63%
183.80
+33.37%
137.81
+17.24%
117.54
Stockholders Equity
2,561.24
+40.07%
1,828.51
+58.95%
1,150.34
+128.02%
504.49
Common Stock Equity
2,561.24
+40.07%
1,828.51
+58.95%
1,150.34
+128.02%
504.49
Capital Stock
1.63
+0.12%
1.63
+0.18%
1.63
+0.18%
1.62
Common Stock
1.63
+0.12%
1.63
+0.18%
1.63
+0.18%
1.62
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
163.16
+0.12%
162.96
+0.16%
162.71
+0.17%
162.43
Ordinary Shares Number
59.55
+0.27%
59.39
+0.36%
59.18
+0.12%
59.10
Treasury Shares Number
103.61
+0.04%
103.57
+0.04%
103.53
+0.21%
103.32
Additional Paid In Capital
2,416.24
+3.20%
2,341.30
+3.31%
2,266.26
+3.02%
2,199.82
Retained Earnings
10,431.28
+6.57%
9,788.66
+6.97%
9,150.82
+7.55%
8,508.59
Gains Losses Not Affecting Retained Earnings
-125.45
+19.21%
-155.28
-15.78%
-134.12
+5.26%
-141.57
Treasury Stock
10,162.46
+0.14%
10,147.79
+0.13%
10,134.25
+0.70%
10,063.98
Other Equity Adjustments
-125.45
+19.21%
-155.28
-15.78%
-134.12
+5.26%
-141.57
Total Equity Gross Minority Interest
2,561.24
+40.07%
1,828.51
+58.95%
1,150.34
+128.02%
504.49
Total Capitalization
3,508.69
+1.55%
3,454.99
-0.02%
3,455.85
+70.29%
2,029.37
Working Capital
908.15
+3.27%
879.35
-8.71%
963.29
-1.52%
978.17
Invested Capital
3,968.69
+14.87%
3,454.99
-1.45%
3,505.85
+68.60%
2,079.37
Total Debt
1,491.08
-12.41%
1,702.34
-30.30%
2,442.26
+46.82%
1,663.41
Net Debt
819.61
-37.01%
1,301.13
-33.63%
1,960.44
+79.14%
1,094.35
Capital Lease Obligations
83.64
+10.26%
75.85
-12.56%
86.75
-2.02%
88.54
Net Tangible Assets
662.98
+1987.82%
-35.12
+95.52%
-784.29
-411.81%
-153.24
Tangible Book Value
662.98
+1987.82%
-35.12
+95.52%
-784.29
-411.81%
-153.24
Current Notes Payable
50.00
Current Provisions
11.95
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
652.55
-14.38%
762.12
+26.43%
602.81
-1.45%
611.66
Cash Flow From Continuing Operating Activities
652.55
-14.38%
762.12
+26.43%
602.81
-1.45%
611.66
Net Income From Continuing Operations
642.63
+0.75%
637.83
-0.69%
642.23
-9.26%
707.75
Depreciation Amortization Depletion
206.24
+7.51%
191.82
+15.62%
165.91
+27.21%
130.42
Depreciation
88.14
+1.29%
87.02
+2.83%
84.62
+17.54%
72.00
Amortization Cash Flow
118.09
+12.68%
104.81
+28.95%
81.28
+39.12%
58.42
Depreciation And Amortization
206.24
+7.51%
191.82
+15.62%
165.91
+27.21%
130.42
Amortization Of Intangibles
118.09
+12.68%
104.81
+28.95%
81.28
+39.12%
58.42
Other Non Cash Items
-2.40
-0.74
-107.42%
10.00
Stock Based Compensation
54.13
+21.07%
44.71
+21.27%
36.87
-13.38%
42.56
Asset Impairment Charge
0.00
Deferred Tax
-14.66
-1571.27%
-0.88
+26.73%
-1.20
+96.26%
-31.99
Deferred Income Tax
-14.66
-1571.27%
-0.88
+26.73%
-1.20
+96.26%
-31.99
Operating Gains Losses
-0.74
Gain Loss On Investment Securities
-0.74
Unrealized Gain Loss On Investment Securities
0.00
0.00
Change In Working Capital
-233.38
-109.56%
-111.37
+53.65%
-240.26
+2.77%
-247.10
Change In Receivables
-55.50
+16.22%
-66.24
-234.69%
49.18
+135.67%
-137.87
Changes In Account Receivables
-55.50
+16.22%
-66.24
-234.69%
49.18
+135.67%
-137.87
Change In Inventory
-65.93
-414.82%
20.94
+146.09%
-45.44
+55.41%
-101.90
Change In Payables And Accrued Expense
-89.01
-244.54%
61.59
+177.44%
-79.52
-230.40%
60.98
Change In Payable
-89.01
-244.54%
61.59
+177.44%
-79.52
-230.40%
60.98
Change In Account Payable
-89.01
-244.54%
61.59
+177.44%
-79.52
-230.40%
60.98
Change In Other Working Capital
0.96
-84.48%
6.17
-40.91%
10.43
-18.89%
12.86
Change In Other Current Assets
-11.56
-136.66%
-4.88
+92.97%
-69.43
-142.86%
-28.59
Change In Other Current Liabilities
-12.34
+90.43%
-128.94
-22.24%
-105.48
-100.61%
-52.58
Investing Cash Flow
-152.25
-6.40%
-143.09
+90.08%
-1,442.27
-1235.84%
-107.97
Cash Flow From Continuing Investing Activities
-152.25
-6.40%
-143.09
+90.08%
-1,442.27
-1235.84%
-107.97
Net PPE Purchase And Sale
-112.75
+20.87%
-142.48
+11.30%
-160.63
+8.69%
-175.92
Purchase Of PPE
-112.75
+20.87%
-142.48
+11.30%
-160.63
+8.69%
-175.92
Capital Expenditure
-112.75
+20.87%
-142.48
+11.30%
-160.63
+12.44%
-183.46
Net Investment Purchase And Sale
0.00
-100.00%
0.88
+4295.24%
-0.02
-100.03%
66.59
Purchase Of Investment
0.00
+100.00%
-3.73
-108.21%
-1.79
+84.30%
-11.41
Sale Of Investment
0.00
-100.00%
4.61
+160.45%
1.77
-97.73%
77.99
Net Business Purchase And Sale
-7.29
-389.93%
-1.49
-300.67%
0.74
-91.67%
8.90
Purchase Of Business
0.00
+100.00%
-1,282.35
0.00
Net Intangibles Purchase And Sale
0.00
0.00
+100.00%
-7.54
Purchase Of Intangibles
0.00
0.00
+100.00%
-7.54
Net Other Investing Changes
-32.21
-1,282.35
Financing Cash Flow
-237.21
+65.95%
-696.67
-192.28%
754.95
+248.14%
-509.63
Cash Flow From Continuing Financing Activities
-237.21
+65.95%
-696.67
-192.28%
754.95
+248.14%
-509.63
Net Issuance Payments Of Debt
-220.00
+69.86%
-730.00
-193.59%
780.00
+1200.00%
60.00
Issuance Of Debt
70.00
-58.82%
170.00
-88.28%
1,450.04
+607.34%
205.00
Repayment Of Debt
-290.00
+67.78%
-900.00
-34.32%
-670.04
-362.10%
-145.00
Long Term Debt Issuance
70.00
-58.82%
170.00
-88.28%
1,450.04
+607.34%
205.00
Long Term Debt Payments
-290.00
+67.78%
-900.00
-34.32%
-670.04
-362.10%
-145.00
Net Long Term Debt Issuance
-220.00
+69.86%
-730.00
-193.59%
780.00
+1200.00%
60.00
Net Common Stock Issuance
-14.67
-8.32%
-13.54
+80.73%
-70.28
+88.77%
-626.06
Common Stock Payments
-14.67
-8.32%
-13.54
+80.73%
-70.28
+88.77%
-626.06
Repurchase Of Capital Stock
-14.67
-8.32%
-13.54
+80.73%
-70.28
+88.77%
-626.06
Proceeds From Stock Option Exercised
20.79
-31.54%
30.37
+1.93%
29.79
-30.39%
42.80
Net Other Financing Charges
-23.33
-241.38%
16.50
+6.89%
15.44
+13.28%
13.63
Changes In Cash
263.10
+438.86%
-77.64
+8.12%
-84.50
-1322.88%
-5.94
Effect Of Exchange Rate Changes
-0.62
-107.84%
7.92
+935.44%
-0.95
+93.58%
-14.77
Beginning Cash Position
325.36
-17.65%
395.08
-17.78%
480.53
-4.13%
501.23
End Cash Position
587.83
+80.67%
325.36
-17.65%
395.08
-17.78%
480.53
Free Cash Flow
539.81
-12.88%
619.64
+40.13%
442.18
+3.26%
428.20
Interest Paid Supplemental Data
44.65
-51.52%
92.10
-2.13%
94.10
+95.70%
48.08
Income Tax Paid Supplemental Data
244.24
+33.21%
183.34
-24.65%
243.32
+51.99%
160.08
Taxes Refund Paid
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category